Evidence map›Paper›PMID 25869663›Full record

ReviewThe Journal of cell biology2015

Recent insights into the cellular biology of atherosclerosis.

Ira Tabas, Guillermo García-Cardeña, Gary K Owens

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 518 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
518citing papers in PubMed, 1 pooled it
42.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

518 citing papers in PubMed, 1 synthesis or guideline pooled it, 997 citations in OpenAlex.

  1. Pooled it
  2. Effect of Flaxseed (Nutrients · 2022
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Aortic Atherosclerosis: An Updated Review of Current Guidelines and Management Approach-A Literature Review.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Application of PLCL as a biodegradable polymer in biomedical engineering.Journal of materials science. Materials in medicine · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Inflammation and the Heart: The Role of Traditional Factors.Cardiology research and practice · 2026
    Review

458 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ira TabasDepartment of Medicine, Department of Pathology and Cell Biology, and Department of Physiology, Columbia University Medical Center, New York, NY 10032 Department of Medicine, Department of Pathology and Cell Biology, and Department of Physiology, Columbia University Medical Center, New York, NY 10032 Department of Medicine, Department of Pathology and Cell Biology, and Department of Physiology, Columbia University Medical Center, New York, NY 10032 iat1@columbia.edu.
Guillermo García-CardeñaProgram in Human Biology and Translational Medicine, Harvard Medical School, Boston, MA 02115 Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.
Gary K OwensRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908.
Brigham and Women's Hospital · USColumbia University Irving Medical Center · USUniversity of Virginia · US

Funding

The Unfolded Protein Response in Sterol CytoxicityR01HL075662 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2004 to 2017
$5.6M
Role of OxPLs and Oct4 in SMC Phenotypic Switching in AtherosclerosisR01HL087867 · NHLBI · UNIVERSITY OF VIRGINIA · PI OWENS, GARY K · 2008 to 2016
$3.5M
Epigenetic Control of Smooth Muscle Cell Lineage and Phenotypic SwitchingR01HL057353 · NHLBI · UNIVERSITY OF VIRGINIA · PI OWENS, GARY K · 2008 to 2016
$3.5M
Therapeutic Reversal of Endothelial Dysfunction in AtherogenesisR44HL118826 · NHLBI · RIPARIAN PHARMACEUTICALS, INC. · PI ADAMS, WILLIAM JAMES, GARCIA-CARDENA, GUILLERMO · 2016 to 2018
$2.8M
REGULATION OF SMOOTH MUSCLE MYOSIN GENE EXPRESSIONR37HL057353 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OWENS, GARY K · 1998 to 2007
$2.3M
Role of IL1b in Regulating SMC and Macrophage Differentiation in AtherosclerosisR01HL121008 · NHLBI · UNIVERSITY OF VIRGINIA · PI OWENS, GARY K · 2014 to 2017
$2.2M
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASER01AG032443 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A · 2010 to 2014
$1.6M
Mechanisms of Defective Efferocytosis in AtherosclerosisR01HL107497 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2012 to 2015
$1.6M
Pharmacological Targeting of Endothelial Dysfunction in AtherogenesisR41HL118826 · NHLBI · RIPARIAN PHARMACEUTICALS, INC. · PI ADAMS, WILLIAM JAMES, GARCIA-CARDENA, GUILLERMO · 2013 to 2014
$541k
NHLBI NIH HHS HL057353NHLBI NIH HHS HL075662NHLBI NIH HHS HL087867NHLBI NIH HHS HL107497NHLBI NIH HHS HL118826NHLBI NIH HHS HL121008NHLBI NIH HHS R01 HL057353NHLBI NIH HHS R01 HL075662NHLBI NIH HHS R01 HL087867NHLBI NIH HHS R01 HL107497NHLBI NIH HHS R01 HL121008NHLBI NIH HHS R37 HL057353NHLBI NIH HHS R41 HL118826NHLBI NIH HHS R44 HL118826NIA NIH HHS AG032443NIA NIH HHS R01 AG032443
6 · The paper itself

Abstract

Atherosclerosis occurs in the subendothelial space (intima) of medium-sized arteries at regions of disturbed blood flow and is triggered by an interplay between endothelial dysfunction and subendothelial lipoprotein retention. Over time, this process stimulates a nonresolving inflammatory response that can cause intimal destruction, arterial thrombosis, and end-organ ischemia. Recent advances highlight important cell biological atherogenic processes, including mechanotransduction and inflammatory processes in endothelial cells, origins and contributions of lesional macrophages, and origins and phenotypic switching of lesional smooth muscle cells. These advances illustrate how in-depth mechanistic knowledge of the cellular pathobiology of atherosclerosis can lead to new ideas for therapy.

Indexed as

AnimalsAtherosclerosisEndothelial CellsEndothelium, VascularHumansMacrophagesMechanotransduction, CellularMuscle, Smooth, VascularMyocytes, Smooth Muscle

Identifiers

PMID25869663
PMCPMC4395483
OpenAlexW1949072443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.